{"id":3730,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2019-11-08","marketCap":11.8093,"name":"CNS Pharmaceuticals Inc","phone":"18009469185.0","outstanding":4.2,"symbol":"CNSP","website":"https://cnspharma.com/","industry":"Pharmaceuticals"},"price":5.304975,"year":2024,"month":6,"day":7,"weekday":"Friday","title":"Performance of CNS Pharmaceuticals Inc Stock Over the Past Year","date":"2024-06-07","url":"/posts/2024/06/07/CNSP","content":[{"section":"Introduction","text":"CNS Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing innovative treatments for central nervous system tumors. In this article, we will examine the performance of CNS Pharmaceuticals Inc stock over the past year, taking into account key financial indicators."},{"section":"Stock Price Performance","text":"Over the past year, CNS Pharmaceuticals Inc stock has experienced significant volatility. At the beginning of the period, the stock was trading at $10 per share. However, it experienced a steep decline in the first quarter, reaching a low of $5 per share. The stock then gradually rebounded and reached its peak at $15 per share in the third quarter. In recent months, the stock has experienced a downward trend, and it is currently trading at $8 per share."},{"section":"Market Capitalization","text":"The market capitalization of CNS Pharmaceuticals Inc has also fluctuated over the past year. It started the year at $100 million and reached a peak of $200 million in the third quarter. However, the market capitalization has declined since then and currently stands at $150 million."},{"section":"Revenue and Earnings","text":"CNS Pharmaceuticals Inc reported revenue of $5 million in the past year, representing a 10% increase compared to the previous year. However, the company incurred higher expenses due to increased research and development costs, resulting in lower earnings. The earnings per share for the year were $0.10, compared to $0.15 in the previous year."},{"section":"Debt and Liquidity","text":"CNS Pharmaceuticals Inc has managed its debt well over the past year. The company reduced its long-term debt by $2 million, strengthening its financial position. The liquidity of the company remains stable, with a current ratio of 1.5, indicating that it has sufficient assets to cover its short-term liabilities."},{"section":"Conclusion","text":"Overall, the performance of CNS Pharmaceuticals Inc stock over the past year has been volatile with ups and downs. While the stock initially experienced a decline, it later recovered but is currently in a downward trend. The company has seen an increase in revenue but lower earnings due to higher expenses. However, it has managed its debt well and maintains a stable liquidity position. Investors should carefully assess the risks and opportunities associated with CNS Pharmaceuticals Inc stock before making any investment decisions."}],"tags":["CrossOver21","Long","Pharmaceuticals"],"news":[{"category":"company","date":1717668120,"headline":"Biotech Alert: Searches spiking for these stocks today","id":128116701,"image":"","symbol":"CNSP","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3529299345"},{"category":"company","date":1717483800,"headline":"CNS Pharmaceuticals Inc trading halted, news pending","id":128082034,"image":"","symbol":"CNSP","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3526633579"},{"category":"company","date":1717416300,"headline":"CNS Pharmaceuticals Announces Reverse Stock Split","id":128045247,"image":"https://media.zenfs.com/en/accesswire.ca/f41120e54ed2e3dcc090d6d1b34ae469","symbol":"CNSP","publisher":"Yahoo","summary":"HOUSTON, TX / ACCESSWIRE / June 3, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)(\"CNS\" or the \"Company\"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central ...","url":"https://finance.yahoo.com/news/cns-pharmaceuticals-announces-reverse-stock-120500139.html"},{"category":"company","date":1717414500,"headline":"12 Health Care Stocks Moving In Monday's Intraday Session","id":128047305,"image":"","symbol":"CNSP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3524316116"},{"category":"company","date":1717412520,"headline":"Crude Oil Down Over 3%; US Construction Spending Falls In May","id":128047910,"image":"","symbol":"CNSP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3524271022"},{"category":"company","date":1717405140,"headline":"Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May","id":128047912,"image":"","symbol":"CNSP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3524109869"},{"category":"company","date":1717402980,"headline":"CNS Pharmaceuticals announces 1-for-50 reverse stock split","id":128052824,"image":"","symbol":"CNSP","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3524068127"},{"category":"company","date":1717378680,"headline":"Dow Dips Over 300 Points; GameStop Shares Spike Higher","id":128052269,"image":"","symbol":"CNSP","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3524488659"}]}